Drugs / Cyclophospahmide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06358573 Background | Oct 2024 → Oct 2028 expected | triple-negative breast carcinoma | Swiss Cancer Institute | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cyclophospahmide | “Cycle 5-8: Doxorubicin or Epirubicin q3W + Cyclophospahmide q3W” NCT06358573 ↗ |